Skip to content
ChickenStockChickenStock
ResearchFilings
← Disclosures

OliX Pharmaceuticals226950

OliX Pharmaceuticals (226950) Amended Material Information, 2026-09-30

Filing date ·

OliX Pharmaceuticals filed a corrective disclosure regarding its submission to New Zealand MedSafe for approval of a Phase 2a clinical trial plan for OLX10212,…

Sign in to read this filing in detail

Continue to the filing details and any available analysis after signing in.

Filing lists and official source links are available without signing in.